Capitalizing on Halal Pharmaceuticals: The Billion-Dollar Path to Ethical Healthcare
Highlights: The halal pharmaceutical market, guided by the holistic approach of nearly two billion Muslims worldwide, is growing. It’s not just about avoiding certain ingredients like pork or alcohol, but ensuring ethical principles are followed throughout the production process. This includes using ingredients from halal animals, maintaining hygiene, minimizing animal testing, and avoiding contamination with non-halal substances.
The market is projected to reach USD 151.5 billion by 2027, driven by the rising Muslim population, increasing awareness of halal principles among health-conscious consumers, and economic opportunities for manufacturers, healthcare providers, and certification bodies.
However, challenges exist, such as the lack of standardized regulations and certification processes, which can create confusion and hinder consumer trust. More investment is needed in research and development to address specific needs and concerns of Muslim patients, particularly in areas like chronic diseases.
A collaborative approach is essential to unlock the full potential of the halal pharmaceutical market, promote ethical and sustainable practices in the healthcare industry, and pave the way for a more inclusive and ethical healthcare landscape for all. This is not just about catering to a specific religious group, but about informing and making all consumers, especially those practicing Islam, more aware of their pharmaceutical needs. The writer emphasizes that opinions expressed are his own.
Link to Original Article